tiprankstipranks
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market

Autolus Therapeutics (AUTL) Financial Statements

Compare
640 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently $375.23M. The company's EPS TTM is $-0.868; its P/E ratio is ―; Autolus Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.12M$ 1.70M$ 6.19M$ 2.33M$ 242.00K
Gross Profit$ -1.27M$ -4.87M$ -131.03M$ -126.32M$ -134.65M
Operating Income$ -241.43M$ -195.03M$ -163.78M$ -164.21M$ -168.15M
EBITDA$ -202.12M$ -156.77M$ -135.54M$ -132.01M$ -160.51M
Net Income$ -220.66M$ -208.38M$ -148.84M$ -142.10M$ -142.09M
Balance Sheet
Cash & Short-Term Investments$ 588.02M$ 239.57M$ 382.44M$ 310.34M$ 153.30M
Total Assets$ 782.73M$ 375.38M$ 490.27M$ 405.56M$ 294.24M
Total Debt$ 52.63M$ 52.97M$ 24.26M$ 21.00M$ 54.16M
Net Debt$ -174.75M$ -186.60M$ -358.18M$ -289.34M$ -99.14M
Total Liabilities$ 355.40M$ 263.91M$ 191.60M$ 92.24M$ 84.20M
Stockholders' Equity$ 427.32M$ 111.47M$ 298.67M$ 313.32M$ 210.03M
Cash Flow
Free Cash Flow$ -206.27M$ -156.57M$ -123.15M$ -126.72M$ -132.44M
Operating Cash Flow$ -206.27M$ -145.59M$ -112.31M$ -117.86M$ -117.76M
Investing Cash Flow$ -394.55M$ -10.99M$ -10.84M$ -8.86M$ -14.68M
Financing Cash Flow$ 589.55M$ -883.00K$ 223.61M$ 284.06M$ 74.42M
Currency in USD

Autolus Therapeutics Earnings and Revenue History

Autolus Therapeutics Debt to Assets

Autolus Therapeutics Cash Flow

Autolus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis